Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese

International Journal of Obesity volume 31, pages 1148–1154 (2007)Cite this article

Abstract

Background:

Contradicting results have been published regarding the effect of conjugated linoleic acid (CLA) on insulin resistance. However, only a few studies have used the euglycemic hyperinsulinemic clamp method, which is considered the standard for measuring insulin resistance.

Objective:

To evaluate if CLA as a mixture of the main isomers trans-10 cis-12 and cis-9 trans-11 affects the insulin resistance in healthy overweight and obese male and female adults.

Design:

The main study was a randomized, double-blind, placebo-controlled trial with change in body composition as primary end point comprising 118 subjects receiving supplementation with either placebo (olive oil) or CLA (Clarinol) for 6 months. A sub-population of 49 subjects agreed additionally to participate in an euglycemic hyperinsulinemic clamp study at baseline and after 6 months of supplementation with study drug. The primary outcome was the change in glucose uptake (M) as measured by the hyperinsulinemic euglycemic glucose clamp method. Secondary outcomes were the correlates between insulin resistance and changes in body composition or blood chemistry parameters. Forty-one subjects completed the clamp test at both time points.

Results:

The median M of the CLA group was 11.0 mg min−1 lean body mass (lbm)−1 (n=24) at baseline, 10.3 mg min−1 lbm−1 (n=24) after 6 months, and the median difference was +0.21 mg min−1 lbm−1 (n=24). The median M of placebo group was 8.4 mg min−1 lbm−1 at baseline and 9.3 mg min−1 lbm−1 after 6 months and the median difference was −0.22 mg min−1 lbm−1 (n=17). No significant (P<0.05) differences were found within groups or between groups. Likewise, the glucose uptake insulin concentration ratio during clamp (M/I) was independent of treatment and time. Homeostasis model assessment (HOMA) and quantitative insulin sensitivity check index derived from fasting glucose and insulin were also independent of treatment and time, and HOMA for the clamp population (n=49) corresponded well with HOMA for the per protocol population (n=83). Correlation analysis showed that changes in M were inversely correlated to changes in glucohemoglobin (P=0.002), but did not correlate with changes in either glucose, insulin, insulin c-peptide, leptin, adiponectin or percent body fat.

Conclusions:

CLA does not affect glucose metabolism or insulin sensitivity in a population of overweight or obese volunteers.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Atkinson RL . Conjugated linoleic acid for altering body composition and treating obesity. In: Yurawecz MP, Mossoba MM, Kramer JKG, Pariza MW, Nelson GJ (eds). Advances in Conjugated Linoleic Acid Research vol. 1 AOCS Champaign: Illinois, 1999. pp 348–353.

    Google Scholar 

  2. Berven G, Bye A, Hals O, Blankson H, Fagertun H, Thom E et al. Safety of conjugated linoleic acid (CLA) in overweight or obese human volunteers. Eur J Lipid Sci Technol 2000; 102: 455–462.

    Article  CAS  Google Scholar 

  3. Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O . Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr 2000; 130: 2943–2948.

    Article  CAS  Google Scholar 

  4. Gaullier JM, Halse J, Høye K, Kristiansen K, Fagertun H, Vik H et al. Conjugated linoleic acid (CLA) supplementation for one year reduces body fat mass in healthy, overweight humans. Am J Clin Nutr 2004; 79: 1118–1125.

    Article  CAS  Google Scholar 

  5. Gaullier J, Halse J, Høye K, Kristiansen K, Fagertun H, Vik H et al. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J Nutr 2005; 135: 778–784.

    Article  CAS  Google Scholar 

  6. Kreider RB, Ferreira MP, Greenwood M, Wilson M, Almada AL . Effects of conjugated linoleic acid supplementation during resistance-training on body composition, bone density, strength, and selected hematological markers. J Strength Cond Res 2002; 3: 325–334.

    Google Scholar 

  7. Larsen TM, Toubro S, Gudmundsen O, Astrup A . Conjugated linoleic acid supplementation for 1 year does not prevent weight or body fat regain. Am J Clin Nutr 2006; 83: 606–612.

    Article  CAS  Google Scholar 

  8. Lowery LM, Appicelli PA, Lemon PWR . Conjugated linoleic acid enhances muscle size and strength gains in novice bodybuilders [Abstract]. Med Sci Sport Exercise 1998; 30: 182.

    Article  Google Scholar 

  9. Riserus U, Berglund L, Vessby B . Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial. Int J Obes Relat Metab Disord 2001; 25: 1129–1135.

    Article  CAS  Google Scholar 

  10. Smedman A, Vessby B . Conjugated linoleic acid supplementation in humans-metabolic effects. Lipids 2001; 36: 773–781.

    Article  CAS  Google Scholar 

  11. Terpstra AHM . Effect of conjugated linoleic acid on body composition and plasma lipids in humans: an overview of the literature. Am J Clin Nutr 2004; 79: 352–361.

    Article  CAS  Google Scholar 

  12. Thom E, Wadstein J, Gudmundsen O . Conjugated linoleic acid reduces body fat in healthy exercising humans. J Int Med Res 2001; 29: 392–396.

    Article  CAS  Google Scholar 

  13. Albers R, van der Wielen RP, Brink EJ, Hendriks HF, Dorovska-Taran VN, Mohede IC . Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) isomers on immune function in healthy men. Eur J Clin Nutr 2003; 57: 595–603.

    Article  CAS  Google Scholar 

  14. Noone EJ, Roche HM, Nugent AP, Gibney MJ . The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br J Nutr 2002; 88: 243–251.

    Article  CAS  Google Scholar 

  15. Aminot-Gilchrist DV, Anderson HDI . Insulin resistance-associated cardiovascular disease: potential benefits of conjugated linoleic acid. Am J Clin Nutr 2004; 79: 1159S–1163S.

    Article  CAS  Google Scholar 

  16. Eyjolfson V, Spriet L, Dyck D . Conjugated linoleic acid improves insulin sensitivity in young, sedentary humans. Med Sci Sport Exercise 2004; 36: 814–820.

    Article  CAS  Google Scholar 

  17. Moloney F, Yeow T, Mullen A, Nolan J, Roche H . Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr 2004; 80: 887–895.

    Article  CAS  Google Scholar 

  18. Riserus U, Arner P, Brismar K, Vessby B . Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 2002; 25: 1516–1521.

    Article  CAS  Google Scholar 

  19. Whigham LD, O'Shea M, Mohede ICM, Walaski HP, Atkinson RL . Safety profile of conjugated linoleic acid in a 12-month trial in obese humans. Food Chem Toxicol 2004; 42: 1701–1709.

    Article  CAS  Google Scholar 

  20. Riserus U, Vessby B, Arnlov J, Basu S . Effects of cis-9, trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr 2004; 80: 279–283.

    Article  CAS  Google Scholar 

  21. Riserus U, Vessby B, Arner P, Zethelius B . Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity. Diabetologia 2004; 47: 1016–1019.

    Article  CAS  Google Scholar 

  22. Riserus U, Basu S, Jovinge S, Fredrikson GN, Arnlov J, Vessby B . Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation 2002; 106: 1925–1929.

    Article  CAS  Google Scholar 

  23. DeFronzo RA, Tobin JD, Andres R . Glucose clamp technique: a method for quantifying insulin resistance. Am J Physiol 1979; 237: E214–E223.

    CAS  Google Scholar 

  24. Stern SE, Williams K, Ferrannini E, DeFronzo RA, Bogardus C, Stern MP . Identification of individuals with insulin resistance using routine clinical measurements. Diabetes 2005; 54: 333–339.

    Article  CAS  Google Scholar 

  25. McAuley KA, Williams SM, Mann JI, Walker RJ, Lewis-Barned NJ, Temple LA et al. Diagnosing insulin resistance in the general population. Diabetes Care 2001; 24: 460–464.

    Article  CAS  Google Scholar 

  26. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402–2410.

    Article  CAS  Google Scholar 

  27. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Haeften TV et al. Use of oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000; 23: 295–301.

    Article  CAS  Google Scholar 

  28. Virtanen KA, Iozzo P, Hällsten K, Huupponen R, Parkkola R, Janatuinen T et al. Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes. Diabetes 2005; 54: 2720–2726.

    Article  CAS  Google Scholar 

  29. Birkeland KI, Kilhovd B, Thorsby P, Torjesen PA, Ganss R, Vaaler S et al. Heterogeneity of non-insulin-dependent diabetes expressed as variability in insulin sensitivity, β-cell function and cardiovascular risk profile. Diabetic Med 2003; 20: 37–45.

    Article  CAS  Google Scholar 

  30. Kamphuis MM, Lejeune MP, Saris WH, Westerterp-Plantenga MS . The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int J Obes Relat Metab Disord 2003; 27: 840–847.

    Article  CAS  Google Scholar 

  31. Song H, Grant I, Rotondo D, Mohede I, Sattar N, Heys S et al. Effect of CLA supplementation on immune function in young healthy volunteers. Eur J Clin Nutr 2005; 59: 508–517.

    Article  CAS  Google Scholar 

  32. Tricon S, Burdge G, Kew S, Banerjee T, Russell J, Grimble R et al. Effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on immune cell function in healthy humans. Am J Clin Nutr 2004; 80: 1626–1633.

    Article  CAS  Google Scholar 

  33. Malpuech-Brugere C, Verboeket-van de Venne WP, Mensink RP, Arnal MA, Morio B, Brandolini M et al. Effects of two conjugated linoleic acids isomers on body fat mass in overweight humans. Obes Res 2004; 12: 591–598.

    Article  CAS  Google Scholar 

  34. McAuley KA, Williams SM, Mann JI, Goulding A, Chisholm A, Wilson N et al. Intensive lifestyle changes are necessary to improve insulin sensitivity: a randomized controlled trial. Diabetes Care 2002; 25: 445–452.

    Article  Google Scholar 

Download references

Acknowledgements

We are very thankful to the clinical nurses Bente Ryen, Lill Johannessen and Sissel Paulsen Sundeng for their active contribution in the success of this study. Lipid Nutrition, a division of Loders Croklaan has supported this study.

Author information

Authors and Affiliations

  1. Scandinavian Clinical Research AS, Kjeller, Norway

    C Syvertsen, J-M Gaullier, M Nurminiemi, K Kristiansen & O Gudmundsen

  2. Diabetes and Overweight Specialist Medical Center, Oslo, Norway

    J Halse

  3. Hedmark Medical Center, Hamar, Norway

    H O Høivik

  4. Lipid Nutrition, Loders Croklaan, Wormerveer, The Netherlands

    A Einerhand & M O'Shea

Authors
  1. C Syvertsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J Halse
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H O Høivik
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J-M Gaullier
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M Nurminiemi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K Kristiansen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A Einerhand
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M O'Shea
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. O Gudmundsen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C Syvertsen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Syvertsen, C., Halse, J., Høivik, H. et al. The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese. Int J Obes 31, 1148–1154 (2007). https://doi.org/10.1038/sj.ijo.0803482

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0803482

Keywords

This article is cited by

Search

Advanced search

Quick links